No Rx Needed for CVS/Caremark: Fool by Numbers
By
Motley Fool Contributors
May 9, 2007
|
On May 8, CVS/Caremark (NYSE: CVS) released first-quarter earnings for the period ended March 31.
- The merger between CVS and Caremark closed on March 22, so the results reflect 10 days of the consolidated company.
- Merger and integration expenses are estimated to have shortened earnings by $25.3 million, lowering shareholder profits a penny.
- While increasing demand for generic drugs curtailed the top line, revenue still posted an impressive 32.1% surge.
- Front-end comparable sales rose a solid 6.6%, driven primarily by health and beauty products, digital photo services, and private label and proprietary brand sales.
(Figures in millions, except per-share data.)
Income Statement Highlights
|
Q1 2007
|
Q1 2006
|
Change
|
|
Sales
|
$13,184.6
|
$9,979.2
|
32.1%
|
|
Net Profit
|
$405.4
|
$326.1
|
24.3%
|
|
EPS
|
$0.43
|
$0.39
|
10.3%
|
|
Diluted Shares
|
939.8
|
848.5
|
10.8%
|
Get back to basics with the income statement.
Margin Checkup
*Expressed in percentage points.
Margins are the earnings engine.
Balance Sheet Highlights
|
Assets
|
Q1 2007
|
Q1 2006
|
Change
|
|
Cash + ST Invest.
|
$738.2
|
$387.1
|
90.7%
|
|
Accounts Rec.
|
$4,485.4
|
$2,015.0
|
122.6%
|
|
Inventory
|
$7,427.1
|
$5,704.8
|
30.2%
|
|
Liabilities
|
Q1 2007
|
Q1 2006
|
Change
|
|
Accounts Payable
|
$3,371.1
|
$2,437.6
|
38.3%
|
|
Long-Term Debt
|
$2,895.4
|
$1,592.2
|
81.8%
|
The balance sheet reflects the company's health.
Cash Flow Highlights
Free cash flow is a Fool's best friend.
Related Foolishness:
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.